Supernus Pharmaceuticals (SUPN) Inventory Average (2012 - 2026)

Supernus Pharmaceuticals (SUPN) has 15 years of Inventory Average data on file, last reported at $84.7 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $84.7 million, up 63.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $84.7 million (up 63.38% YoY), and the FY2025 annual result was $68.3 million, up 3.78% from the prior year.
• Inventory Average climbed to $84.7 million in Q1 2026 per SUPN's latest filing, from $80.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $91.3 million in Q1 2023 and troughed at $46.7 million in Q2 2025.
• A 5-year average of $76.1 million and a median of $80.9 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2025: Inventory Average soared 77.32% in 2022, then tumbled 34.76% in 2025.
• A 5-year view of Inventory Average shows it stood at $87.4 million in 2022, then dropped by 7.91% to $80.4 million in 2023, then dropped by 26.49% to $59.1 million in 2024, then jumped by 36.79% to $80.9 million in 2025, then climbed by 4.74% to $84.7 million in 2026.
• Business Quant data shows SUPN's Inventory Average at $84.7 million in Q1 2026, $80.9 million in Q4 2025, and $61.7 million in Q3 2025.